Pharmaceutical Industry

HealthMark Cuban warns Trump’s tariffs mean his Cost Plus Drugs ‘won’t have a choice’ but to raise prices for consumers
By Ani FreedmanApril 1, 2025

TechAs a kid, she raised money to cure cystic fibrosis. Now she’s the CEO of a $2.6 billion genetic testing company
By Andrew NuscaMarch 31, 2025

By AFPMarch 27, 2025

TechSanofi’s chief digital officer says remote work means employees lose the ‘serendipity’ needed to innovate
By Ryan HoggMarch 27, 2025

Tech‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
By Ryan HoggMarch 25, 2025

By Ashleigh Furlong and BloombergMarch 17, 2025

By Michelle WernerMarch 10, 2025

CommentaryThe crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
By Wendy BarnesMarch 4, 2025

LeadershipA few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million
By Lila MacLellanMarch 1, 2025

HealthGSK could double CEO Emma Walmsley’s pay to $27 million in bid to bring U.K. exec salaries in line with the U.S.
By Ryan HoggFebruary 28, 2025

By Madison Muller and BloombergFebruary 26, 2025

LeadershipBayer CEO Bill Anderson on diversity initiatives, new menopause drugs and how to tame a runaway bureaucracy
By Fortune EditorsFebruary 26, 2025

By KFF Health News and Arthur AllenFebruary 25, 2025

By Bloomberg, Madison Muller, Ike Swetlitz and Naomi KresgeFebruary 21, 2025
Most Popular



